About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Effectiveness of HPV Vaccine in Thai Adult Women | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT03763565

Effectiveness of HPV Vaccine in Thai Adult Women

* Background: The majority of the burden of HPV-related cervical cancer is in developing countries while most of the effectiveness reports of HPV vaccination are currently coming from developed countr...

Lead sponsor: Mahidol University•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Mahidol University

Collaborators

National Vaccine Institute, Thailand
Chulalongkorn University
National Cancer Institute, Thailand
Bumrungrad International Hospital
Siriraj Hospital

Age

25 - 53 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•(vaccinated group)
•Thai women aged 20-45 years at the time of HPV vaccination
•Received at least 1 dose of bivalent or quadrivalent HPV vaccine at least 5 years ago
•Willing to provide written informed consent and receive Pap smear \& HPV genotyping (only for those who need specimen collection for cervical cytology and HPV genotyping result)
•(control group)
•Thai women without history of HPV vaccination
•Received Pap smear result at their ages 20-45 years at least 5 years ago
•Willing to provide written informed consent and receive Pap smear \& HPV genotyping (only for those who need specimen collection for cervical cytology and HPV genotyping result)

Exclusion Criteria

•Known pregnancy
•History of hysterectomy or excisional treatment of the cervix
•Known increased risk of bleeding
•Not willing to provide written informed consent

Related studies

ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

NCT06535139 · Papillomavirus Vaccines

RECRUITINGPhase 4

Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV

NCT05266898 · Papillomavirus Vaccines, Human Immunodeficiency Virus, and more

Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples

NCT06598176 · Uterine Cervical Neoplasm, Uterine Cervical Dysplasia, and more

Conservative Management of HSIL in Patients With Future Pregnancy Aspiration

NCT04783805 · Cervical Intraepithelial Neoplasia, Squamous Intraepithelial Lesions of the Cervix, and more

Active Not RecruitingNA

Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination

NCT05148559 · Papillomavirus Vaccines

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 5, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment993

Start dateNov 2018

Last updatedJun 5, 2023

Condition

Uterine Cervical Dysplasia Papillomavirus Vaccines

Locations shown

Bumrungrad International Hospital

Bangkok

King Chulalongkorn Memorial Hospital

Bangkok

National Cancer Institute, Thailand

Bangkok

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 5, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions